http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-207693625-U
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3c72b0d3bc2f8a3fc4ed462749b6563 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B17-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M31-00 |
| filingDate | 2017-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a23a8a87892c9ab4489f29bc3329abd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e69174929310019ea3b18981e801c87e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b8ce61d9a6a4ab4a678ca591b60a270b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b085ba53d9cc417519cea5f5e6a668e |
| publicationDate | 2018-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-207693625-U |
| titleOfInvention | Lung therapeutic device with treatment channel |
| abstract | The utility model discloses the lung therapeutic devices that a kind of band treats channel, are mainly made of plug members, passage component and one or two switch block；Wherein, the side fitting of the plug members is located in inner bronchial wall；The passage component runs through the plug members；Part of the plug members in addition to the passage component is being airtight along the direction of bronchus length；One or two switch blocks are arranged in the one or both ends of the passage component；Wherein, the end of the passage component is closed and closed to the switch block under normal conditions, and after the switch block is opened by external force, the passage component perforation, the lung therapeutic device is formed along bronchus length direction and is connected to.The lung therapeutic device of the utility model, which is placed in the bronchus of pulmonary tuberculosis target hole region proximal end, can completely cut off outside air, and provides channel and aspirated or conveyed drug therapy to the remaining mycobacterium tuberculosis in pulmonary tuberculosis target cavity. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113456155-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109077770-A |
| priorityDate | 2017-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 37.